These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37747445)

  • 41. Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients.
    Raichlin E; McConnell JP; Bae JH; Kremers WK; Lerman A; Frantz RP
    Transplantation; 2008 Apr; 85(7):963-8. PubMed ID: 18408575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Lp-PLA2, a biomarker of vascular inflammation and vulnerability of atherosclerosis plaques].
    Bonnefont-Rousselot D
    Ann Pharm Fr; 2016 May; 74(3):190-7. PubMed ID: 26499399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Energy Intake and Plasma Adiponectin as Potential Determinants of Lipoprotein-Associated Phospholipase A
    Ntzouvani A; Giannopoulou E; Fragopoulou E; Nomikos T; Antonopoulou S
    Lipids; 2019 Oct; 54(10):629-640. PubMed ID: 31489677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential Expression of Lipoprotein-Associated Phospholipase A2 in Monocyte Subsets: Impact of Uremia and Atherosclerosis.
    Ulrich C; Trojanowicz B; Fiedler R; Kohler F; Wolf AF; Seibert E; Girndt M
    Nephron; 2017; 135(3):231-241. PubMed ID: 27992874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of Hypoxia-Inducible Factor-1α (HIF1A) and Lp-PLA2 in Low, Intermediate, and High Cardiovascular Disease Risk Population.
    Heriansyah T; Chomsy IN; Kumboyono K; Pratiwi PA; Wihastuti TA
    Vasc Health Risk Manag; 2020; 16():507-513. PubMed ID: 33299319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy.
    Zhai Y; Cao X; Liu S; Shen Y
    Ann Med; 2023; 55(2):2230446. PubMed ID: 37566692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of the Relationship Between the Changes of Serum SAA, LP-PLA2, sCD40L and Carotid Atherosclerosis Plaque in Patients with Acute Cerebral Infarction.
    Xu Y; Xu Y; Li Y; Liu R; Wu A; Zhou R; Mao D
    Altern Ther Health Med; 2024 Sep; 30(9):47-53. PubMed ID: 38330557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
    Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
    Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.
    Yang F; Ma L; Zhang L; Wang Y; Zhao C; Zhu W; Liang W; Liu Q
    Heart Vessels; 2019 Oct; 34(10):1608-1614. PubMed ID: 30963302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease.
    Mourouzis K; Siasos G; Oikonomou E; Zaromitidou M; Tsigkou V; Antonopoulos A; Bletsa E; Stampouloglou P; Vlasis K; Vavuranakis M; Tousoulis D
    Lipids Health Dis; 2021 Feb; 20(1):12. PubMed ID: 33583415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study.
    Daniels LB; Laughlin GA; Sarno MJ; Bettencourt R; Wolfert RL; Barrett-Connor E
    J Am Coll Cardiol; 2008 Mar; 51(9):913-9. PubMed ID: 18308160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
    Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
    BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis.
    Kolasa-Trela R; Fil K; Bazanek M; Grudzień G; Sobczyk D; Sadowski J; Undas A
    Clin Chem Lab Med; 2012 Oct; 50(10):1825-31. PubMed ID: 23089713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The correlation between lipoprotein associated phospholipase A
    Chen YH; Li WC; Chen YC; Yeh WC; Yu W; Hung HY; Jie XX; Chen JY
    Int J Immunopathol Pharmacol; 2021; 35():20587384211048562. PubMed ID: 34796753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China.
    Huang Y; Wu Y; Yang Y; Li W; Lu J; Hu Y
    Sci Rep; 2017 Nov; 7(1):16092. PubMed ID: 29170433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.
    Ragab SM; Safan MA; Obeid OM; Sherief AS
    Hematology; 2015 May; 20(4):228-38. PubMed ID: 25056687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between lipoprotein-associated phospholipase A
    Xu XY; Guo L; Wang Q; Yu XB; Li L; Wei Q
    Clin Chim Acta; 2020 Nov; 510():228-231. PubMed ID: 32679127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Relationship Between Lipoprotein-Associated Phospholipase A(2), Cholesteryl Ester Transfer Protein and Lipid Profile and Risk of Atherosclerosis in Women with Iron Deficiency Anaemia.
    Yang S; Chen XY; Xu XP
    Clin Lab; 2015; 61(10):1463-9. PubMed ID: 26642708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Replacing with whole grains and legumes reduces Lp-PLA2 activities in plasma and PBMCs in patients with prediabetes or T2D.
    Kim M; Jeung SR; Jeong TS; Lee SH; Lee JH
    J Lipid Res; 2014 Aug; 55(8):1762-71. PubMed ID: 24904022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.